A 34-year-old man was admitted to our hospital with diabetic ketoacidosis due to fulminant type 1 diabetes. The patient's pancreatic exocrine and endocrine functions were as follows: the bentiromide (PABA) test value on day 14 was 33.9%, thus indicating exocrine dysfunction. One year and a half later, the PABA test value had improved to 71.0%. On the other hand, the serum C-peptide level after meal ingestion was under the detection limit. The mechanisms underlying pancreatic exocrine abnormalities seem to be different from those underlying accelerated pancreatic beta-cell failure in patients with fulminant type 1 diabetes.
Introduction
Fulminant type 1 diabetes (FT1DM) is defined as a subtype of type 1 diabetes with a markedly rapid progression and almost complete destruction of pancreatic beta cells (1) . The clinical features of FT1DM are significantly different from those of autoimmune type 1 (type 1A) diabetes. FT1 DM is characterized by a remarkable onset with ketosis or ketoacidosis, a lack of islet-related autoantibodies and a high serum pancreatic enzyme concentration (1) . Abnormalities of the exocrine pancreas are often observed around symptom onset; however, little is known about the pancreatic exocrine function during the course of FT1DM. We herein report a case of FT1DM in which the pancreatic exocrine function recovered over time in spite of diminished insulin secretion.
Case Report
A 34-year-old man was admitted to our hospital with diabetic ketoacidosis. He had ingested raw oysters (Crossostrea nippona) four days before admission. He suffered from fatigue, diarrhea, nausea and vomiting two days before admission. On the day of admission, he visited a clinic and was given intravenous fluid supplementation. However, he developed atrial fibrillation and was transferred to our emergency room. His arterial blood pH was 7.14 and his bicarbonate level was 7.7 mmol/L. He had markedly increased levels of ketone bodies and serum potassium (7.4 mEq/L). After admission, he was treated in the intensive care unit. His plasma glucose level was 56.3 mmol/L and his HbA1c level was 6.0% (NGSP). His serum and urinary C-peptide levels were very low (0.06 ng/mL and 2.1 μg/day, respectively). He had no islet-associated autoantibodies [anti-glutamic acid (GAD) antibodies or insulinoma-associated antigen-2 (IA-2) antibodies] (Table) . These findings were consistent with a diagnosis of FT1DM. He had no history of diabetes or chronic pancreatitis.
The patient's serum amylase level was 308 IU/L (normal range: 60-200 IU/L) at the time of his admission to our hospital; however, it rose to 511 IU/L the next day and normalized within one week. No abnormal findings were observed in the pancreas on echography. The patient had elevated lipase and elastase-1 levels (131 IU/L (normal range: 11-53 IU/L) and 520 ng/dL (normal range: 100-400 ng/dL), respectively) on day 2 of admission, and his lipase level normalized in four weeks. After receiving treatment for ketoacidosis, the patient did not have any diarrhea. The pancreatic exocrine and endocrine functions were as follows: the bentiromide test value on day 14 was 33.9% [the lower limit of normal is 70% (2)], indicating exocrine dysfunction. This value increased to 59.5% at six months and 55.6% at one year after having shown a mild improvement. One year and a half later, the bentiromide test value had improved to 71.0% (Figure) . On the other hand, the serum C-peptide level after meal ingestion was under the detection limit (<0.03 ng/mL), even two years after admission. After recovering from diabetic ketoacidosis, the patient was treated with multiple insulin injection therapy.
Discussion
The characteristic features at onset of FT1DM include involvement of the exocrine pancreas as well as pancreatic islets. Elevation of the serum pancreatic exocrine enzyme levels is a common feature (1), and swelling of the pancreas is sometimes observed. Histological analyses reveal mononuclear infiltration of both the endocrine and exocrine pancreas at disease onset (3, 4) . The area of the alpha cells in patients with recent-onset FT1DM significantly decreased compared to that observed in autoimmune type 1 patients and control subjects. The area of the alpha cells has been reported to not decrease significantly in patients with autoimmune type 1 diabetes compared with that observed in control subjects (3) (4) (5) . Although elevated serum pancreatic enzyme levels have been reported at disease onset, little is known about the exocrine function (6). Kahara et al. reported the time course of increases in the serum amylase levels; however, the exocrine function was not evaluated (7). Exocrine pancreatic insufficiency was observed in our case around disease onset; however, the patient's pancreatic exocrine function recovered over time in spite of diminished insulin secretion. Sayama et al. reported that, in their study, all islets were atrophic and distorted, although no edematous changes, necrosis, hemorrhage, suppuration, cyst formation or apparent atrophy of the exocrine pancreas were apparent, in pancreatic tissue obtained by biopsy from patients with recentonset FT1DM (5). The reason why the impaired insulin secretion was not restored while the exocrine function improved may be that the beta-cell damage had progressed to an irreversible stage. The mechanisms underlying pancreatic exocrine abnormalities seem to be different from those underlying accelerated pancreatic beta-cell failure in patients with FT1DM. Interferon-γ and CXC chemokine ligand 10 (CXCL10) are strongly coexpressed in all subtypes of islet cells, including beta-cells and alpha-cells, although no CXCL10 is expressed in pancreatic acinar or ductal cells in pancreata obtained from patients with FT1DM (3). Tanaka et al. reported that the CXCL10 and CXCR3, the receptors for CXCL10, activation circuit represents a unique mechanism of rapid beta-cell destruction in FT1DM (3). The possible causes of exocrine failure in patients with diabetes include an autoimmune process associated with type 1 diabetes, a direct trophic effect of insulin on the exocrine pancreas, microangiopathy and atherosclerosis (8) . An investigation of the pancreatic exocrine function in a large cohort of patients with diabetes showed the primary factor associated with pancreatic exocrine failure in patients with typical autoimmune type 1 diabetes to be the duration of diabetes (8) . This observation suggests that the mechanisms underlying exocrine failure in FT1DM patients are different from those underlying exocrine failure in patients with autoimmune type 1 diabetes. Future investigation of the exocrine pancreatic function is required to elucidate the pathophysiology of FT1DM.
Viral infections with subsequent immunological mechanisms represent one of the leading candidates for destruction of beta-cells in patients with FT1DM (1, (3) (4) (5) . In such cases, FT1DM presumably develops after an infection with the Norovirus because the Norovirus is considered to be the primary pathogen in Japanese food poisoning cases caused by raw oysters (9) .
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